Ask AI

Biosimilars: An Overview for Clinicians

In this educational activity experts in oncology and immunology answer your most frequently asked questions about biosimilars including:
-How biosimilars differ from their reference biologic and small molecule generics
-Safety efficacy and regulatory approval pathways
-Potential role in oncology and immunology

Share

Program Content

No activities added yet

No activities added yet

Supporters

Supported by an educational grant from

Pfizer, Inc.